Novel angiotensin-converting enzyme inhibitory peptides from caseins and whey proteins of goat milk

Journal of Advanced Research

Volumn 8, Issue 1, 2017, Pages 63-71

  Ibrahim, Hisham R ^a   Ahmed, Ahmed S ^b   Miyata, Takeshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b South Valley University   (Egypt)

Author keywords

Angiotensin I converting enzyme (ACE); Anti hypertension; Bioactive peptides; Caseins; Goat milk; Whey

Indexed keywords

EID: 85007038144     PISSN: 20901232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jare.2016.12.002     Document Type: Article

References (30)

1. [1] Brandelli, A., Daroit, D.J., Corrêa, A.P.F., Whey as a source of peptides with remarkable biological activities. Food Res Int 73 (2015), 149–161.
2. [2] Nongonierma, A.B., FitzGerald, R.J., Strategies for the discovery, identification and validation of milk protein-derived bioactive peptides. Trends Food Sci Technol 50 (2016), 26–43.
3. [3] Martin, P., Cebo, C., Miranda, G., Milk proteins|inter-species comparison of milk proteins: quantitative variability and molecular diversity A2 - fuquay. John, W., (eds.) Encyclopedia of dairy sciences, 2nd ed., 2011, Academic Press, San Diego, 821–842.
4. [4] Park, Y.W., Bioactive components in goat milk. Bioactive components in milk and dairy products, 2009, Wiley-Blackwell, 43–81.
5. [5] Simos, Y., Metsios, A., Verginadis, I., D'Alessandro, A.G., Loiudice, P., Jirillo, E., et al. Antioxidant and anti-platelet properties of milk from goat, donkey and cow: an in vitro, ex vivo and in vivo study. Int Dairy J 21 (2011), 901–906.
6. [6] Carver, J.D., Advances in nutritional modifications of infant formulas. Am J Clin Nutr 77 (2003), 1550S–1554S.
7. [7] Chessex, P., Watson, C., Kaczala, G.W., Rouleau, T., Lavoie, M.E., Friel, J., et al. Determinants of oxidant stress in extremely low birth weight premature infants. Free Radic Biol Med 49 (2010), 1380–1386.
8. [8] Correa, A.P.F., Daroit, D.J., Coelho, J., Meira, S.M.M., Lopes, F.C., Segalin, J., et al. Antioxidant, antihypertensive and antimicrobial properties of ovine milk caseinate hydrolyzed with a microbial protease. J Sci Food Agric 91 (2011), 2247–2254.
9. [9] Collins, R., MacMahon, S., Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Brit Med Bull 50 (1994), 272–298.
10. [10] Angelo, A., Marco, C., Drug-induced angioedema without urticaria. Drug Safety 24 (2001), 599–606.
11. [11] Chen, J., Wang, Y., Ye, R., Wu, Y., Xia, W., Comparison of analytical methods to assay inhibitors of angiotensin I-converting enzyme. Food Chem 141 (2013), 3329–3334.
12. [12] Ahmed, S.A., El-Bassiony, T., Elmalt, L.M., Ibrahim, H.R., Identification of potent antioxidant bioactive peptides from goat milk proteins. Food Res Int 74 (2015), 80–88.
13. [13] Matsui, T., Matsufuji, H., Osajima, Y., Colorimetric measurement of angiotensin I-converting enzyme inhibitory activity with trinitrobenzene sulfonate. Biosci Biotechnol Biochem 56 (1992), 517–518.
14. [14] Norris, R., Poyarkov, A., O'Keeffe, M.B., FitzGerald, R.J., Characterisation of the hydrolytic specificity of Aspergillus niger derived prolyl endoproteinase on bovine beta-casein and determination of ACE inhibitory activity. Food Chem 156 (2014), 29–36.
15. [15] Minervini, F., Algaron, F., Rizzello, C.G., Fox, P.F., Monnet, V., Gobbetti, M., Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl Environ Microbiol 69 (2003), 5297–5305.
16. [16] Groziak, S.M., Miller, G.D., Natural bioactive substances in milk and colostrum: effects on the arterial blood pressure system. Brit J Nutr 84 (2000), 119–125.
17. [17] Asoodeh, A., Memarpoor, Y., Mina, C., Jamshid, K., Purification and characterisation of angiotensin I converting enzyme inhibitory peptides from lysozyme hydrolysates. Food Chem 131 (2012), 291–295.
18. [18] Yamada, A., Sakurai, T., Ochi, A., Matsuyama, E., Yamauchi, K., Abe, F., Novel angiotensin I-converting enzyme inhibitory peptide derived from bovine casein. Food Chem 141 (2013), 3781–3789.
19. [19] Matsui, T., Li, C.H., Osajima, Y., Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Pept Sci 5 (1999), 289–297.
20. [20] Himaya, S.W.A., Ngo, D.H., Ryu, B., Kim, S.K., An active peptide purified from gastrointestinal enzyme hydrolysate of Pacific cod skin gelatin attenuates angiotensin-1 converting enzyme (ACE) activity and cellular oxidative stress. Food Chem 132 (2012), 1872–1882.
21. [21] Ko, S.C., Kang, N., Kim, E.A., Kang, M.C., Lee, S.H., Kang, S.M., et al. A novel angiotensin I-converting enzyme (ACE) inhibitory peptide from a marine Chlorella ellipsoidea and its antihypertensive effect in spontaneously hypertensive rats. Process Biochem 47 (2012), 2005–2011.
22. [22] Meisel, H., Multifunctional peptides encrypted in milk proteins. BioFactors 21 (2004), 55–61.
23. [23] Cheung, H.S., Wang, F.L., Ondetti, M.A., Sabo, E.F., Cushma, D.W., Binding of peptide substrate and inhibitors of angiotensin-converting enzyme. J Biol Chem 255 (1980), 401–407.
24. [24] Castellano, P., Aristoy, M.C., Sentandreu, M.A., Vignolo, G., Toldra, F., Peptides with angiotensin I converting enzyme (ACE) inhibitory activity generated from porcine skeletal muscle proteins by the action of meat-borne Lactobacillus. J Proteom 89 (2013), 183–190.
25. [25] Fujita, H., Yokoyama, K., Yoshikawa, M., Classification and antihypertensive activity of angiotensin I-converting enzyme inhibitory peptides derived from food proteins. J Food Sci 65 (2000), 564–569.
26. [26] Tavares, T., del Mar Contreras, M., Amorim, M., Pintado, M., Recio, I., Malcata, F.X., Novel whey-derived peptides with inhibitory effect against angiotensin-converting enzyme: in vitro effect and stability to gastrointestinal enzymes. Peptides 32 (2011), 1013–1019.
27. [27] Meisel, H., Walsh, D.J., Murray, B.A., ACE inhibitory peptides. Mine, Y., Shahidi, F., (eds.) Nutraceutical proteins and peptides in health and disease, 2006, CRC Press, Taylor and Francis Group, New York (New York), 269–315.
28. [28] Aredes Fernández, P.A., Stivala, M.G., Rodríguez Vaquero, M.J., Increase in antioxidant and antihypertensive activity by Oenococcus oeni in a yeast autolysis wine model. Biotechnol Lett 33 (2011), 359–364.
29. [29] Hernández-Ledesma, B., Miralles, B., Amigo, L., Ramos, M., Recio, I., Identification of antioxidant and ACE-inhibitory peptides in fermented milk. J Sci Food Agric 85 (2005), 1041–1048.
30. [30] Moutinho, C.G., Matos, C.M., Teixeira, J.A., Balcao, V.M., Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art. J Drug Target 20 (2012), 114–141.